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ABSTRACT

For this research project, I propose a method for the analysis of glycated lysozyme using Matrix
Associated Laser Desorption / Ionization-Time of Flight Mass spectrometry (MALDI-TOF MS).
Glycation or "Maillard reaction" is a non-enzymatic reaction that occurs between amino acid
residues, usually primary and secondary amines, of proteins and the carbonyl group of reducing
sugars to yield Schiff bases. The glycation mechanism occurs between the carbonyl group of the
reducing sugars and a primary amine by nucleophilic addition, resulting in the formation of a
Schiff base. The Schiff base can then rearrange into the more stable Amadori product which is
the first level of protein glycation. By processes such as oxidation, dehydration, and
condensation, the Amadori product rearranges in time to form a heterogeneous group of
compounds referred to advanced glycation end products (AGEs). Carnosine, a dipeptide
consisting of β-alanine and histidine, has been shown to have anti-glycating characteristics that
can hinder the damaging impact of aldo- and keto-sugars through oxidation, and it also defends
against such age-stimulating processes as glycation, oxidation, and protein cross-linking.
Lysozyme is an enzyme capable of destroying the bacterial cell wall, and it acts as protection
from bacterial infection. The goal of this project was to determine the initial glycation sites on
chicken and human lysozyme in vitro, determine how carnosine affects the initial glycation of
lysozyme and the formation of AGE structures, and investigate how glycation affects the
enzymatic activity of the enzyme. Lysozyme was incubated with D-glucose and D-galactose for
three days at 37°C in the presence and absence of carnosine and analyzed by MALDI-TOF mass
spectrometry. Lysozyme was primarily found to condense with one sugar molecule, and the
preferred amino acid site of glycation for chicken lysozyme was identified as Lysine-115 which
is not located near the catalytic cleft of the enzyme. In fact, the enzymatic activity of chicken
ix

lysozyme did not change significantly when it was glycated using my glycation conditions.
When both chicken and human lysozyme was incubated with sugars in the presence of carnosine,
I found that carnosine did not inhibit the initial glycation reaction between lysozyme and Dgalactose or D-glucose. The final experiment was to determine the effect of carnosine on the
formation of AGE structures on both chicken and human lysozyme after the initial glycation
reaction had occurred. The results of these experiments indicated that carnosine can decelerate or
hinder the formation of AGE structures that can be obtained after the initial glycation of the
protein.

x

INTRODUCTION
For this research project, I propose a method for the analysis of glycated lysozyme using
Matrix Associated Laser Desorption / Ionization-Time of Flight Mass spectrometry (MALDITOF MS). The goal of this project is to determine the initial glycation sites on chicken and
human lysozyme, determine how carnosine affects the initial glycation of lysozyme and the
formation of AGE structures, and investigate how glycation affects the enzymatic activity of the
enzyme.
Lysozyme
Lysozyme is a protein that was discovered and characterized by Alexander Fleming in
1922. It was the first enzyme whose tertiary protein structure was obtained by X-ray
crystallography.1 The name (lysozyme) was very suitable for this protein, because the first part
lyso- refers to the ability to lyse bacteria and the second part -zyme because of its enzymatic
activity. Lysozyme obtained from the egg white of hen eggs is a small enzyme protein that
possesses a molecular weight about 14600 Da. and consists of 129 amino acids. From X-ray
crystallography data, it was determined that lysozyme has about six disulfide bridges that
provide stability to the protein structure.1 Naturally occurring lysozyme can be found in animal
tissues, organs, serum, tears, mucus, and saliva. Lysozyme also possess huge commercial
potential, such as use as a food preservative, because of its ability to lyse bacteria and the fact
that it is stable through a wide temperature and pH range.2
Lysozyme is an enzyme capable of destroying the bacterial cell wall, and it acts as
protection from bacterial infection.3 Lysozyme hydrolyzes the β (1-4) glycosidic linkage from Nacetylmuramic acid (NAM or MurNAc) to N-acetylglucosamine (NAG or GlcNAc) in particular
polysaccharides as shown in Figure 1 below.3 The linking oxygen that connects NAM and NAG

1

came from a hydroxyl group located on NAG. Lysozyme cleaves this bond which called the β
(1-4) NAM-NAG glycosidic bond, because it originated from C-1 of NAM and the oxygen from
the OH- group from the C-4 of NAG. This peptidoglycan consists of alternating chains of -NAGNAM- units. The activity of the lysozyme enzyme can be measured in an activity assay by
monitoring the lysis of the gram-positive bacterium Micrococcus lysodeikticus substrate by UVVis absorption spectrometry.
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Figure 1: Diagram of the lysozyme cleavage site on a peptidoglycan. The lysozyme enzyme
cleaves after a β (1-4) linkage in the alternating NAG-NAM polysaccharide component of
bacterial cell walls.4
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Hen Egg White Lysozyme
Hen egg white (HEW) possesses lysozyme by 3.5% of the total protein in the Hen Egg,
and lysozyme serves as protection against bacteria and a source of protein for the chick.5 Hen
egg white lysozyme is one of the most significant types of lysozyme, which has been studied in a
detailed manner.3 It is a small protein with a single polypeptide chain that consists of 129 amino
acid subunits bonded together on the inside by four disulfide bonds between the residues: Cys6Cys12, Cys30-Cys115, Cys64-Cys80 and Cys76-Cys94. Its molecular weight is about 14,307
Da.6 The conformation of lysozyme is nearly elliptical with dimensions 30 X 30 X 45 A˚,
according to its shape by X-rays that have been clarified by David Philips in 1965 (Figure 2).3

Figure 2: Tertiary structure of hen egg white lysozyme.7
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Human Lysozyme:
Human lysozyme contains about 130 amino acid subunits and is found in secretions (such
as milk, tears, spit, mucus, and perspiration), as well as in leukocytes and kidneys. Human
lysozyme is able to hydrolyze the β (1-4) glycosidic linkage from N-acetylmuramic acid (NAM
or MurNAc) to N-acetylglucosamine (NAG or GlcNAc) that take place in the cell wall of
microorganisms.8 Human milk possesses lysozyme that acts as a protection for the newborn
because of its antimicrobial activity.9 The amount of lysozyme that can be found in the milk of
dairy animals (such bovine and caprine) are about 1600 to 3000 times lower than the amount of
human milk; therefore, the bottle-fed babies are 3 times more likely to have diarrheal disease. An
adult human milk has roughly 400 μg /mL lysozyme, while bovine and caprine milk has on
average 0.130 μg /mL and 0.250 μg /mL of lysozyme.9
Glycation of protein:
Glycation or "Maillard reaction" is a non-enzymatic reaction that occurs between amino
acid residues, usually primary and secondary amines, of proteins and the carbonyl group of
reducing sugars to yield Schiff bases. In food chemistry, the reducing sugar, such as D-glucose,
fructose, lactose, and their derivatives, are considered the main source of the carbonyl group. The
N-terminal amino group and the ε-amino group of lysine residues are considered the main source
of amines.10
The glycation mechanism occurs between the carbonyl group of the reducing sugars and
a primary amine by nucleophilic addition, resulting in the formation of a Schiff base. The Schiff
base can then rearrange into the more stable Amadori product which is the first level of protein
glycation. By processes such as oxidation, dehydration, and condensation, the Amadori product
rearranges in time to form a heterogeneous group of compounds referred to Advanced Glycation
4

End Products (AGEs).11 The most common type of AGE structure formed on lysine residues is
carboxymethyllysine (CML).12 The reaction between the reducing sugar D-glucose and a lysine
residue is shown in Figure 3.
The initial Schiff base formed upon glycation is a fully reversible product, and the sugar
molecules can be hydrolyzed back off of the protein. Once the structure rearranges to the more
stable Amadori product, the sugar residue is permanently attached to the protein. Over time, the
sugar molecule attached to the protein can undergo oxidation, dehydration, and condensation
reactions to form the AGE structures and even form cross-linked structures between amino acid
residues within the same protein or between proteins which alters the structure and function of
these proteins.
Protein glycation is influenced by many factors in vivo, including the nature and
concentration of the carbonyl substrates, the availability and reactivity of the amino groups on
proteins, and the chemical or enzymatic degradation of glycation products and their renal
clearance.13 The post-translational modification of proteins by sugars has been demonstrated in
diabetes and classical galactosemia. The excess D-glucose in the bloodstream of patients
suffering from diabetes results in the glycation of serum proteins, especially hemoglobin and
albumin. In fact, glycated proteins may be the main pathogenic mediators of diabetic
complications.14 In patients with galactosemia, high levels of blood D-galactose can promote the
galactation of serum proteins.15
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Figure 3: Reaction scheme for the glycation of lysine residues with D-glucose.16
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Carnosine:
The dipeptide carnosine is a small molecule made up of two amino acids: β-alanyl-Lhistidine (Figure 4). It was discovered over 100 years ago in Russia from beef extract; therefore,
its name came from carno, carnis: meat.17 It is one of the most common dipeptides in mammals.
It has the ability to retard cellular senescence and renews cultured human fibroblasts; therefore, it
has been implicated as an anti-aging agent.18 It also plays an important role in the prevention of
protein degradation. Carnosine is found in long-lived tissue such as the brain, kidney and muscle
in a highly concentrated amount (up to 20 mM); however, its biological function is still under
investigation. A comparison between carnosine concentrations in different animal species show
that increased carnosine amounts correlates with increased life expectancy. 19 Carnosine has been
shown to have anti-glycating characteristics that can hinder the damaging impact of aldo- and
keto-sugars through oxidation, and it also defends against such age-stimulating processes as
glycation, oxidation, and protein cross-linking.18 Studies have shown that it can oppose the
glycation of proteins and act to lessen some diabetic complications. None of the studies on the
anti-glycating effect of carnosine have any direct evidence pertaining to its anti-glycating effect
or mechanism of action. One of my aims for this work is to determine how carnosine affects the
initial glycation of lysozyme and the formation of (advanced glycation endproduct) AGE
structures.

Figure 4: Carnosine structure: Beta-Alanyl-L-Histidine.20
7

MALDI-TOF MS:
MALDI-TOF MS (Matrix Associated Laser Desorption Ionization-Time of Flight Mass
Spectrometry) is one of the numerous analytical technique that can be utilized for the
biochemical analysis of peptides, proteins, polysaccharides, fatty acids, metabolites, and DNA
molecules.21 In the late 1980s, Hillenkamp, Karas, and Tanaka at the University of Munster in
Germany developed the use of MALDI-TOF MS in the analysis of large nonvolatile molecules,
such as DNA, proteins, and peptides.19 The advantages of this technique are the accuracy, the
speed, and the ease of use which allow researchers to measure the molecular weights of these
molecules using a small amount of a sample. MALDI-TOF mass spectrometry has been
successfully used for the analysis of glycated peptides and proteins22, 23 making it an ideal choice
for the analysis of the glycated lysozyme generated in this research project.
The MALDI-TOF Components:
MALDI is an ionization process which can generate gas-phase ions of intact proteins and
peptides while the TOF is a sensitive mass analyzer used to separate the gas-phase ions by m/z
value based upon flight times through a drift free region.24 Every mass spectrometer possesses
four main components: an ionization source which creates gas-phase ions, a mass analyzer which
separates the ions by their m/z ratio, an ion detector, and a vacuum system. The ionization source
is responsible for producing the gas phase ions of the molecules which can then be separated by
the mass analyzer. Only ions, either positive or negative, will be affected by the mass analyzer.

8

Figure 5: The MALDI-TOF mass spectrometer components.25

A good ionization leads to a successful analysis of the target molecules. The resulting
ions could be either singly or multiple charged depending upon the ionization source used to
create the ions. The ions that were produced by the ionizer will enter into the analyzer and get
separated based upon their m/z ratio. There are different types of mass analyzers that differ from
one another depending on the principle of the separation. The ions must not be allowed to react
or collide with other gaseous molecules within the system which would interfere with their
separation; therefore, the mass analyzer acts in a vacuum. The separation process in the mass
analyzer and the ionization process occur very fast, thus, an efficient detection must be applied in
order to obtain an accurate analysis. The detector, usually an electron multiplier tube, will detect
the amount of ions striking its surface and convert this signal into an electrical signal (current).
Finally, the data system will convert the current signals into a mass spectrum.

9

Figure 6: Basic components of a linear MALDI-TOF mass spectrometer.26

A linear MALDI-TOF mass spectrometer has a simple instrumental design (Figure.6).
For MALDI-TOF analysis, the sample is uniformly mixed with excess matrix which absorbs the
photons from the laser and converts it to heat energy (Figure.5). Some of the matrix heats rapidly
and is vaporized along with the sample creating gas phase molecules. The matrix molecules then
collide with the sample molecules donating a proton to the sample molecule upon collision
creating (M+H)+ sample gas phase ions. Generally only +1 ions are created for peptide samples,
and both +1 and +2 ions are created for protein samples. The TOF mass analyzer separates ions
based upon their m/z ratio. This mass analyzer is based on the rule that when a temporally and
spatially well specific group of ions of differing mass/charge (m/z) ratios are subjected to the
same applied electric field (K.E. = [mv2]/2 = zeEs where K.E. = kinetic energy; m = the mass of
the ion; v = velocity of the ion; z = number of charges; e = the charge on an electron in
coulombs; E = electric field gradient; and s = the distance of the ion source region) and let to
drift in area of constant electric field, then they are going to pass this area in a time which
depends upon their m/z ratios.26 Consequently, the time of ion flight differs according to the
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mass-to-charge ratio (m/z) value of the ion. Each time the laser pulses, a packet of ions is
generated and sent down the flight tube for detection.
Previous Experiments:
A few research labs have previously studied the glycation of lysozyme. Researchers at
McGill University used electrospray ionization mass spectrometry (ESI-MS to study the
glycation of lysozyme by both D-glucose and D-fructose under dry heating conditions.27 They
employed harsh glycation conditions which lead to the production of highly glycated chicken
lysozyme which formed adducts containing up to 5 sugar residues. This study showed that
lysozyme could be glycated in the presence of D-glucose; however, no actual sites of glycation
were identified. In addition, the authors could not be certain which amino acid residues (Arg,
Lys, His, Cys) were being glycated using these particular glycation conditions.
In 2010, Yukiko Maekawa and coworkers studied the glycation reaction of chicken
lysozyme incubated with D-glucose at 37°C for 3, 9, 24, and 72 hours.28 They analyzed the
glycated lysozyme by MALDI-TOF mass spectrometry and found that the glycation reaction
progressed within several hours under physiological conditions at 37°C. The resultant mass
spectra can be seen in Figure.7 below. They also determined that lysozyme could take up to 10
D-glucose residues after 10 weeks of reaction.

11

Figure 7: Reaction time-dependent MS spectra of glycated lysozyme a) 3 h, b) 9 h, c) 24 h,
and d) 72 h after starting the glycation reaction. The arrow shows native lysozyme (m/z
14331).28

Researchers at the University of Wroclaw combined isotopic labelling and LCMS to
identify glycated peptides produced from the tryptic digest of glycated lysozyme.29 They used
harsh glycation conditions of heating the lysozyme in the presence of excess D-glucose at 50°C
for 14 days. Under these conditions, they identified glycated peptides which contained modified
lysine residues from all six lysine residues present in chicken lysozyme. In addition, they
identified several AGE structures located on arginine residues within the protein. When the
researchers changed their glycation conditions to more resemble physiological conditions
(incubation of protein in huge excess of D-glucose at 37°C for 40 days), they identified early
glycation products on lysine residues 33, 96, and 97 within the amino acid sequence of chicken
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lysozyme and AGE structures on several arginine residues. D-glucose was the only sugar used
for these experiments.
Eric Dongliang Ruan and coworkers studied the glycation of lysozyme with D-glucose
incubated at 50°C for up to 30 days.30 They used a sugar to protein ratio of 1:6 for their
experiments. Using both MALDI-TOF and ESI-MS, they were able to identify four lysine
residues (1, 13, 97, and 116) that were glycated after 30 days of reaction. The MALDI-TOF
spectra generated for the digested glycated lysozyme is shown in Figure 8 below.

Figure 8: MALDI-TOF-MS spectra of digested glucosylated lysozyme (50°C for 30 days)
with two potential glycated peptides (mass shift of 162 Da), comparison to original
lysozyme (data not shown).30

Previous students in Frost’s lab have studied the effect of carnosine on protein glycation.
Derek Collins determined the effect of carnosine on the initial glycation of cytochrome c with Dgalactose by monitoring the mass shifts that occurred when the protein was glycated (+162
Da/D-galactose addition). Protein samples incubated with D-galactose in the presence and
absence of carnosine were analyzed daily for eleven days by MALDI-TOF mass spectrometry.
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The resultant mass spectra can be seen in Figure 9. The glycation pattern when carnosine is
added to the incubation mixture remains similar to when it is absent, indicating that carnosine
does not inhibit the initial glycation reaction between cytochrome c and D-galactose.31 Since
carnosine did not inhibit the initial attachment of a sugar molecule to the cytochrome c protein,
Miss Emma Gardner studied the effect of carnosine on the formation of the advanced glycation
endproducts that occurs over time after the sugar is added to the protein. She determined that
carnosine inhibited the formation of AGE structures on glycated cytochrome c (Figure.10). In
particular, glycated Lys-13 was not converted to the AGE structure CML (carboxy methyl
lysine) when carnosine was added to the incubation mixture. Lys-13 is located right next to the
heme group in cytochrome c, so she speculated that the heme group could have participated in
the conversion of the glycated lysine residue into the AGE structure and the carnosine could
have been associating with the heme group preventing it from participating in the conversion.16
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Figure 9: MALDI-TOF mass spectra of the +2 ion of bovine Cyt c incubated at 37°C in the
presence of D-galactose for 2 days (A), 4 days (B), 7 days (C), and 11 days (D). Bovine
cytochrome c incubated at 37°C in the presence of D-galactose and carnosine for 2 days
(E), 4 days (F), 7 days (G), and 11 days (H).31
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Figure 10: MALDI-TOF mass spectra of the +2 ion of glycated cytochrome c incubated at
37°C in the absence of carnosine (A) and in the presence of carnosine (B) for 42 days.16

For this research project, I propose studying the glycation of lysozyme with D-glucose
and D-galactose under physiological conditions using short reaction times to identify
physiologically relevant initial sites of glycation. In addition, I want to correlate these sites of
glycation with the enzymatic activity of lysozyme to determine whether the initial glycation of
lysozyme would have any effect on its reactivity.
Plasma lysozyme mainly comes from the disintegration of lysozyme containing cells of
the blood (neutrophils and monocytes).32 Plasma lysozyme was found to have a half-life of only
75 minutes in a rat using

125

I-labeled rat lysozyme, and the kidneys were found to take up
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considerable amounts of lysozyme and retain the lysozyme for up to 4 days.33 Thus,
physiologically relevant glycation of lysozyme would occur in a shorter time frame than used in
the previous experiments described above. Therefore, I propose glycating lysozyme at 37°C for
two to three days and determining the most reactive amino acid sites towards glycation.
I also want to study the effect of carnosine on the initial glycation of lysozyme and the
formation of AGE products. Previous experiments described above indicated that carnosine did
not inhibit the initial glycation reaction but did inhibit the formation of AGE structures once
glycation had occurred. These experiments were performed using the protein cytochrome c
which contains a covalently attached heme group. It was speculated that the heme group may
have been involved with the formation of the AGE structures that was inhibited by carnosine.
Therefore, I wanted to repeat these experiments with a small protein that did not contain a heme
group to see if the results would be the same as those with cytochrome c. Lysozyme is an ideal
small protein for this study.

17

EXPERIMENTAL SECTION
Glycation of Chicken Lysozyme:
Briefly, 3 mg of lysozyme from chicken egg white (Sigma L4919) was dissolved into 300
μL of phosphate buffered saline (PBS). This solution was divided into three equal volumes and
placed into three new microcentrifuge tubes. The total volume of the first tube was increased to
500 μL with PBS and labelled as control. For the second tube, 35 mg of D-galactose (Acros)
was added, and the volume was diluted with PBS to a final volume of 500 μL. For the third tube,
35 mg of D-glucose (Sigma G7528) was added, and the volume was diluted to a final volume of
500 μL with PBS. All three solutions were vigorously vortexed until all the solid had been
dissolved into the solution. The solutions were then incubated for two days at 37°C in a sand
bath. The entire procedure was repeated using an incubation period of three days at 37°C. After
incubation, an Ultracel YM-33 kDa cutoff filter was used to remove excess sugar from the
sample prior to further analysis.
Glycation of Human Lysozyme:
The same procedure used for chicken lysozyme above was followed for the glycation of
human lysozyme (recombinant protein, expressed in rice, Sigma L1667). The human
recombinant protein has significantly higher bioactivity than the chicken lysozyme.
Effect of Carnosine on initial glycation of Lysozyme:
Briefly, 3 mg of chicken lysozyme (from chicken egg white) was dissolved into 300 mL
of phosphate buffered saline (PBS). This solution was divided into three equal volumes and
placed into three new microcentrifuge tubes. The total volume of the first tube was increased to
500 μL with PBS and labelled as control. For the second tube, 35 mg of D-galactose was added,
and the volume was diluted with PBS to a final volume of 500 μL. For the third tube, 35 mg of
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D-galactose and 50 mg of carnosine was added resulting in roughly a 2:1 molar ratio of
carnosine to D-galactose, and the volume was diluted to a final volume of 500 μL with PBS. All
three solutions were vigorously vortexed until all the solid had been dissolved into the solution.
The solutions were then incubated for up to 11 days at 37°C in a sand bath. Aliquots of intact
proteins were removed from the incubation mixtures each day during the 11 day incubation
period and analyzed by MALDI-TOF mass spectrometry. The entire procedure was repeated
using D-glucose as the reducing sugar.
The same procedure above was also used to study the effect of carnosine on the initial
glycation of human lysozyme. The only difference in the procedure was that initially 3 mg of
human recombinant protein was dissolved into 300 μL of PBS then split into three sample
fractions.
Determining the Effect of Carnosine on AGE Structure Formation:
Glycated chicken lysozyme was prepared by incubating 2 mg of lysozyme with 70 mg of
D-galactose in 500 μL of PBS, pH 7.4 for 3 days at 37°C. After incubation, an Ultracel YM-33
kDa cutoff filter was used to remove excess D-galactose from the sample prior to further
analysis. The protein sample obtained after filtering was diluted to a volume of 500 μL with PBS
and 250 μL of sample was transferred to a new microcentrifuge tube. Carnosine was added to
one sample at a final concentration of 10 mM, and both samples were diluted to a total volume of
500 μL with PBS and allowed to incubate at 37°C for up to 42 days. A control sample of
unglycated lysozyme was also incubated at 37°C for 42 days along with the glycated protein
samples. Aliquots of intact proteins were periodically removed from each sample for analysis by
mass spectrometry. The entire procedure was repeated using the human recombinant lysozyme
protein. D-galactose was the only reducing sugar analyzed for these experiments.
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Sodium Borohydride Reduction:
The Schiff base structure is not very stable making it difficult to analyze by MALDI-TOF
mass spectrometry. To increase the stability of these structures, I reduced the Schiff base
structure and even the Amadori structure to alcohols using sodium borohydride (NaBH4). A
newly prepared 100 mM solution of sodium borohydride (3.8 μg of NaBH4 dissolved in 1.0 mL
of 0.004N NaOH) was immediately added to each of the lysozyme protein samples in a 1:1
volume ratio. The solutions were incubated for 1 hour at room temperature, and the reactions
were terminated by the addition of 1N HCl (1:12.5 vol/vol). After the addition of HCl, the
mixtures were allowed to sit at room temperature for at least 5 min to make sure that the reaction
was completely terminated. The pH of the samples was then adjusted to a pH of about 8 using
100 mM Tris buffer, pH 8.5.
Analysis of Intact Protein by MALDI-TOF Mass Spectrometry:
Protein samples were purified using C4 ZipTips (Millipore) and analyzed on a Bruker
Autoflex MALDI-TOF mass spectrometer with instrument settings optimized for intact protein
analysis. Prior to analysis, the protein preparations (0.7 μL) were each mixed with a 50%
aqueous acetonitrile solution (0.7 μL) of saturated α-cyano-4-hydroxy-cinnamic acid containing
0.05% TFA as matrix, spotted onto a stainless steel sample plate and allowed to air dry. The
mass spectra were recorded in positive ion mode with a 60 nanosecond delay in the m/z range
from 4000 to 20,000. Typically, 2000 spectra were accumulated with 50 laser shots for each
sample spot analyzed. Analysis of data was performed using FlexAnalysis and ClinProTools
(Bruker Daltonics Inc. Billerica, MA).
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Analysis of Tryptic Digests of Proteins by Mass Spectrometry:
The sodium borohydride reduced lysozyme protein samples adjusted to pH 8 were
digested with trypsin (1:100 w/w) overnight at room temperature. Trypsin would lyse the amide
bond of the protein at the C-terminal side of arginine and lysine residues; however, trypsin would
be unable to lyse a lysine residue with a sugar attached to it. The resultant tryptic peptides
produced were purified with C18 ZipTips (Millipore) and analyzed on a Bruker Autoflex
MALDI-TOF mass spectrometer (Billerica, MA) to produce a peptide fingerprint mass spectrum
which allowed us to determine candidate glycated peptides for further analysis. Prior to mass
spectral analysis, the peptide preparations (0.7 μL) were mixed with a 50% aqueous acetonitrile
solution (0.7 μl) of saturated α-cyano-4-hydroxy-cinnamic acid (CHCA), spotted onto a stainless
steel sample MALDI plate sample and allowed to air dry. The mass spectra were recorded in
positive ion mode with a 60 nsec delay in the m/z range from 500 to 3500. Roughly 2000 spectra
were accumulated with 50 laser shots for each sample spot analyzed. The resulting peptide mass
fingerprint spectra obtained was used to identify glycated peptides by comparing the
experimental peptide molecular weights with the molecular weights of peptides obtained from a
theoretical digest of lysozyme with trypsin.
The tryptic peptides were also fractionated on 10μm spherical C18 resins (YMC, Inc. Milford,
MA)

and eluted directly into the electrospray source of a ThermoFinnigan LCQ mass

spectrometer (ThermoScientific, Waltham, MA) equipped with a quadrupole ion trap mass
analyzer. The loading of peptides onto the columns was performed using a helium bomb. Once
applied to the columns, the peptides were first washed with 0.1% acetic acid for 3 minutes and
were then collectively eluted from the columns with 50% acetonitrile in 0.1% acetic acid at a
flow rate of 2 μL/min using the helium bomb. The column eluates directed into the electrospray
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source were analyzed by MS and tandem mass spectrometry (CID fragmentation with He)
favoring isolation and fragmentation of doubly charged ions. CID mass spectra were generated
for potentially glycated peptide identified by MALDI-TOF mass spectrometry to confirm the
sites of glycation in the lysozyme protein.
The ESI/MS system was operated with the Xcalibur software (version 2.0, ThermoFinnigan),
with the same software used also for data analysis. The mass spectrometer was set to function in
the positive ion mode with parameters optimized during direct infusion of peptide standards with
solvent. Nitrogen was used as the sheath gas (setting at 60), and ultrapure helium was used as the
collision gas. The ion spray voltage was set as 4.5 kV and the capillary temperature was 210°C.
Lysozyme Enzymatic Assay:
For this experiment, chicken lysozyme was used to determine the effect of glycation on
the enzymatic activity of lysozyme. According to the manufacturer, this assay procedure could
not be used for the recombinant human lysozyme protein.
The lysozyme assay that I performed used Micrococcus lysodeikticus bacterial cells as a
substrate for the lysozyme. The enzymatic rate determination (A450, Light path = 1 cm) depends
on the following reaction:

According

to

the

assay

procedure

obtained

on

Sigma’s

website...

(http://www.sigmaaldrich.com/technical-documents/protocols/biology/enzymatic-assay-oflysozyme.html), one unit of lysozyme should produce a change in absorbance at a wavelength of
450 nm of 0.001 per minute at pH 6.24 and 25°C using a suspension of Micrococcus
lysodeikticus as substrate in a 2.6 ml reaction mixture. Therefore, by monitoring the change of
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absorbance over time at this wavelength, I was able to determine the rate of the enzymatic
reaction for unglycated and glycated lysozyme protein samples. The absorbance was measured
on a Cary 50 Scan UV-Visible spectrophotometer.
For each enzymatic assay performed, fresh suspensions of Micrococcus lysodeikticus
were prepared by dissolving the cells in 66 mM Potassium Phosphate Buffer, pH 6.24, to create a
0.015% (w/v) Micrococcus lysodeikticus Cell Suspension. The absorbance of the solution was
then checked to be sure that the starting absorbance values were between 0.7 to 0.9. For the
analysis, 100 μL of the lysozyme solutions were added to 2.5 mL of the substrate suspension in a
cuvette tube. The solution was immediately mixed by inversion, the cuvette was placed in the
Cary UV-Visible spectrophotometer, and the absorbance values were recorded over a period of
five minutes. The start time after mixing was kept constant for all samples assayed. The
spectrophotometer was run in kinetics mode, and the rate of the reaction over the first 2 minutes
was obtained using the instrument software assuming first order reaction kinetics.
Five solutions were assayed for this experiment. The lysozyme solutions were glycated
using the same procedure as described in a previous section, except all concentration were
doubled to obtain good assay results. Briefly, 12 mg of chicken lysozyme was dissolved into 600
μL of phosphate buffered saline (PBS). This solution was divided into three equal volumes and
placed into three new microcentrifuge tubes. The total volume of the first tube was increased to
1.0 mL with PBS and labelled as control. For the second tube, 140 mg of D-galactose was added,
and the volume was diluted with PBS to a final volume of 1.0 mL. For the third tube, 140 mg of
D-glucose was added, and the volume was diluted to a final volume of 1.0 mL with PBS. All
three solutions were vigorously vortexed until all the solid had been dissolved into the solution.
The solutions were then incubated at 37°C in a sand bath for up to 33 days. In addition, two more
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control samples of 140 mg of D-galactose in 1.0 mL of PBS and 140 mg of D-glucose in 1.0 mL
of PBS were incubated at 37°C for up to 33 days. Sample aliquots of all five sample solutions
were removed at multiple time points to perform enzymatic assay experiments.
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RESULTS AND DISCUSSION

1- Analysis of Glycated Lysozyme
A. Chicken Lysozyme
Chicken lysozyme was incubated with D-glucose and D-galactose for 2 or 3 days at
37°C. The excess sugar was then removed using a 3 KDa cutoff filter, and the protein was
purified and concentrated using C18 ZipTips and analyzed by MALDI-TOF mass spectrometry.
The basic experimental protocol is shown in Figure.11 below. Figure.12 shows the MALDI-TOF
mass spectra of the +2 ion of chicken lysozyme incubated with sugar at 37°C for 2 days. Initial
protein glycation results in the formation of Schiff base and Amadori structures which would
result in an increase of 162 Da to the protein for every sugar molecule attached. Since I am
looking at the +2 ion of lysozyme, I should see a shift of 81 Da for every sugar molecules
attached to lysozyme. There is a small amount of glycated protein seen in the spectra. The
spectrum of unmodified chicken lysozyme (Figure.12A) showed a prominent single peak
centered at m/z= 7,153. Under my conditions of incubation, which is biological conditions, I can
see that the protein had begun to add some D-galactose molecules (Figure.12B) and D-glucose
molecules (Figure.12C), but the glycated protein signal is weak. Therefore, I decided to incubate
the proteins with the sugars for 3 days to see if this would result in a higher production of
glycated protein. Figure 13 shows the results of MALDI-TOF mass spectra of the +2 ion of
chicken lysozyme incubated at 37°C for 3 days with D-galactose and D-glucose. Again, very
little signal from glycated lysozyme was observed in the spectra (Figure 13B and 13C).
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Figure 11: The experimental protocol for MALDI-TOF analysis of glycated lysozyme.
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Figure 12: MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated at 37°C
for 2 days in the absence of sugar (A), and in the presence of D-galactose (B), and in the
presence of D-glucose (C).
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Figure 13: MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated at 37°C
for 3 days in the absence of sugar (A), and in the presence of D-galactose (B), and in the
presence of D-glucose (C).
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Schiff base structures are unstable, especially under the ionization conditions employed
for MALDI-TOF mass spectrometry, making it difficult to analyze glycated proteins. Thus,
sodium borohydride was utilized to reduce the samples in order to obtain a more stable glycation
product to facilitate the analysis of glycated proteins. The Schiff base group is reactive making
the structure less stable and could be causing the sugar to come off the protein during the
MALDI desorption and/or ionization process. Reducing the structure with sodium borohydride
(NaBH4) would decrease the reactivity of this group making the molecule more stable (Figure
14). Likewise reducing the reactive carbonyl group of the Amadori structure to an alcohol would
create a more stable structure which would hold up better during the MALDI.
desorption/ionization process. Every molecule of reduced sugar added to the protein would result
in a protein mass shift of 164 Da. Since I am looking at the +2 ion of lysozyme, I should observe
a mass shift of 82 Da for every sugar molecule attached to the protein.

Figure 14: Reduction of glycated lysine structures with sodium borohydride.
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Figure.15 shows the results of MALDI-TOF mass spectra of the +2 ion of chicken
lysozyme incubated at 37°C for 2 days with sugar and reduced with sodium borohydride prior to
mass spectral analysis. The mass spectrum for lysozyme incubated with D-galactose (Figure
15B) showed that lysozyme could be glycated with one D-galactose molecule under my
incubation conditions. In fact, there is a small peak in the spectrum indicating the presence of
protein modified with two D-galactose molecules. Likewise, when lysozyme was incubated with
D-glucose, the protein was glycated with one sugar molecule, and a second molecule of sugar
was beginning to attach to the protein. When the incubation period was extended to three days,
the MALDI-TOF spectra of the resulting glycated proteins did not show much difference in the
amount of glycation (Figure 16).
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Figure 15: Reduced MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated
at 37°C for 2 days in the absence of sugar (A), and in the presence of D-galactose (B), and
in the presence of D-glucose (C). All samples were reduced with NaBH4 prior to analysis.
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Figure 16: Reduced MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated
at 37°C for 3 days in the absence of sugar (A), and in the presence of D-galactose (B), and
in the presence of D-glucose (C). All samples were reduced with NaBH4 prior to analysis.

32

B. Human Lysozyme:
The glycation of human lysozyme was analyzed in the same manner as chicken lysozyme
(Figure 11). Human lysozyme was incubated with D-galactose and D-glucose for 3 days at
37°C. I only used this glycation condition, because these were the conditions that produced
enough glycated chicken lysozyme without overly glycating the protein. When the protein
samples were reduced with sodium borohydride, the mass spectra revealed that roughly one
sugar molecule was attached to the protein (Figure 17). The unmodified protein (Figure 17A)
showed a prominent peak at about m/z 7340. Upon glycation with D-galactose (Figure 17B) and
D-glucose (Figure 17C), the spectra contained protein peaks at about 82 Da higher than the
unmodified protein indicating the addition of a sugar residue. In addition, the spectra revealed
that a second molecule of D-galactose was just beginning to attach to the protein (Figure 17B).
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Figure 17: Reduced MALDI-TOF mass spectra of the +2 ion of human lysozyme incubated
at 37°C for 3 days in the absence of sugar (A), and in the presence of D-galactose (B), and
in the presence of D-glucose (C). All samples were reduced with NaBH4 prior to analysis.
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2- Effect of Carnosine on the Initial Glycation Reaction:
A. Chicken Lysozyme:
In order to study the effect of carnosine on the initial glycation reaction, I incubated
samples of chicken lysozyme with D-galactose and D-glucose for 3 days at 37°C in the presence
and absence of carnosine. The same basic protocol shown in Figure 11 was followed for these
experiments. I was able to determine the extent of glycation for lysozyme in the presence of
carnosine by monitoring the mass shifts that occur when the protein was glycated (+82 Da/Dgalactose addition). The MALDI-TOF mass spectra for lysozyme incubated with D-galactose
and D-glucose are shown in Figures 18 and 19, respectively. The signal for the glycated protein
(+81 Da) is weak, so I again reduced the protein samples with sodium borohydride. The
MALDI-TOF mass spectra for the reduced protein samples are shown in Figures 20 and 21. The
signal for the glycated protein is much better after reduction showing that the protein could take
up to 2 D-galactose molecules, ∆m/z 82 Da/sugar residue (Figure 20B), and up to 2 D-glucose
molecules (Figure 21B). The glycation pattern when carnosine is added to the incubation mixture
(Figure 20C and 21C) remains similar to when it is absent, indicating that carnosine does not
inhibit the initial glycation reaction between lysozyme and D-galactose or D-glucose. In fact,
carnosine may be aiding in the glycation of the protein and the formation of AGE structures. A
previous student in Dr. Frost’s lab conducted this same experiment with cytochrome c and
carnosine and observed similar results (described in introduction).
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Figure 18: MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated at 37°C
for 3 days in the absence of sugar (A), and in the presence of D-galactose (B), and in the
presence of D-galactose and carnosine (C).
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Figure 19: MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated at 37°C
for 3 days in the absence of sugar (A), and in the presence of D-glucose (B), and in the
presence of D-glucose and carnosine (C).
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Figure 20: Reduced MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated
at 37°C for 3 days in the absence of sugar (A), and in the presence of D-galactose (B), and
in the presence of D-galactose and carnosine (C). All samples were reduced with NaBH4
prior to analysis.
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Figure 21: Reduced MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated
at 37°C for 3 days in the absence of sugar (A), and in the presence of D-glucose (B), and in
the presence of D-glucose and carnosine (C). All samples were reduced with NaBH4 prior
to analysis.
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B. Human Lysozyme:
I also studied the effect of carnosine on the initial glycation of human lysozyme. I
incubated human lysozyme with D-galactose and D-glucose for 3 days at 37°C in the presence
and absence of carnosine. The same basic protocol shown in Figure 11 was followed for these
experiments. All samples were reduced with sodium borohydride prior to mass spectral analysis.
The MALDI-TOF mass spectra for lysozyme incubated with D-galactose (Figure 22) and Dglucose (Figure 23) are shown below. The glycation pattern when carnosine is added to the
incubation mixture (Figure 22C and 23C) remains similar to when it is absent (Figure 22B and
23B), indicating that carnosine does not inhibit the initial glycation reaction between lysozyme
and D-galactose or D-glucose. In fact, the addition of carnosine to the incubation mixture may
actually be promoting the formation of AGE structures. These results are the same as those
obtained for both chicken lysozyme and cytochrome c.
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Figure 22: Reduced MALDI-TOF mass spectra of the +2 ion of human lysozyme incubated
at 37°C for 3 days in the absence of sugar (A), and in the presence of D-galactose (B), and
in the presence of D-galactose and carnosine (C). All samples were reduced with NaBH4
prior to analysis.
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Figure 23: Reduced MALDI-TOF mass spectra of the +2 ion of human lysozyme incubated
at 37°C for 3 days in the absence of sugar (A), and in the presence of D-glucose (B), and in
the presence of D-glucose and carnosine (C). All samples were reduced with NaBH4 prior
to analysis.
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3- Effect of Carnosine on Advanced Glycation Endproduct Formation:
A. Chicken Lysozyme:
In order to study the effect of carnosine on the formation of AGE structures, I initially
incubated samples of chicken lysozyme without any sugar and with D-galactose for 3 days at
37°C. After incubation was complete, all excess sugar was removed using an Ultracel YM-33
kDa cutoff filter, and the remaining glycated protein solution was split into two equal portions.
Carnosine was added to one sample to a final concentration of 10 mM, and both samples were
diluted to 500 μL total volume with PBS. The unglycated protein and the glycated protein
samples (with and without carnosine) were then incubated at 37°C for 42 days. Aliquots of
protein were removed periodically and analyzed by MALDI-TOF mass spectrometry. The basic
experimental protocol is shown in Figure 24. The resultant MALDI-TOF mass spectra for the
protein samples after 28 days of incubation (Figure 25) and 42 days (Figure 26) are shown
below. The arrows in the figures indicate the presence of AGE structures. The glycated chicken
lysozyme that was not incubated with carnosine (Figure 26B) has a more prominent peak in the
spectra at about m/z 7181 (indicated by the arrow) than when the glycated protein was incubated
in the presence of carnosine. This peak had a mass that was about 58 Da (29 Da for the +2 ion)
greater than the mass of the unmodified protein that would indicate the formation of an AGE
structure. A known AGE structure that is formed between sugar and lysine residues is the
carboxymethyllysine structure shown in Figure 3. This modification would result in the addition
of 58 Da to the molecular weight of the protein. The addition of carnosine to the mixture (Figure
26C) decreases the formation of the AGE peak. In fact, the amount of glycation in general
decreases when carnosine is added. Based on these results, this experiment suggests that
carnosine can decelerate or hinder the formation of AGE structures that can be obtained after the
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initial glycation of the protein. Recall that the formation of a Schiff base structure is an
equilibrium reaction. Carnosine may actually serve to help shift this equilibrium back to the
unmodified protein thus reversing the initial glycation of the lysozyme protein.

Figure 24: Experimental protocol for the study of the effect of carnosine on AGE structure
formation.
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Figure 25: MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated at 37°C
for 28 days. Nonglycated lysozyme (A) and glycated lysozyme incubated in the absence of
carnosine (B) and in the presence of carnosine (C). The arrow indicates the presence of
AGE structures.
45

Figure 26: MALDI-TOF mass spectra of the +2 ion of chicken lysozyme incubated at 37°C
for 42 days. Nonglycated lysozyme (A) and glycated lysozyme incubated in the absence of
carnosine (B) and in the presence of carnosine (C). The arrow indicates the presence of
AGE structures.
46

B. Human
The experiment to study the effect of carnosine on the formation of AGE structures was
repeated using human lysozyme. The same experimental protocol outlined in Figure 24 was
used for this experiment, except the glycated human lysozyme was only incubated for 8 days
in the presence and absence of carnosine instead of 42 days because the intact protein began to
degrade. The resultant MALDI-TOF mass spectra for the protein samples after 8 days of
incubation are shown in Figure 27. Again, the presence of AGE structures (indicated by an
arrow on Figure 27B) can be seen in the glycated protein sample that did not contain
carnosine. This modified peak is much decreased in the glycated protein sample that contained
carnosine (Figure 27C). Again, these results support the conclusion that carnosine can
decelerate or hinder the formation of AGE structures that can be obtained after the initial
glycation of the protein.
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Figure 27: MALDI-TOF mass spectra of the +2 ion of human lysozyme incubated at 37°C
for 8 days. Nonglycated lysozyme (A) and glycated lysozyme incubated in the absence of
carnosine (B) and in the presence of carnosine (C). The arrow indicates the presence of
AGE structures.
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4- Identification of Glycation Sites:
A. Chicken Lysozyme:
When lysozyme was incubated with D-galactose for 3 days at 37°C, the protein added
one molecule of sugar and began to add a second molecule (Figure 16B). My next goal was to
determine the amino acid sites of glycation of lysozyme with D-galactose and D-glucose.
Previous experiments conducted in the Frost lab identified glycation sites on only lysine residues
of albumin and cytochrome c when these proteins were incubated with D-galactose and Dglucose using the same incubation conditions employed for my experiments.26 Therefore, lysine
residues are the most likely sites for glycation on lysozyme as well. The amino acid sequence for
chicken lysozyme is shown in Figure 28 with all six lysine residues highlighted.
1 MRSLLILVLC FLPLAALGKV FGRCELAAAM KRHGLDNYRG YSLGNWVCAA KFESNFNTQA
61 TNRNTDGSTD YGILQINSRW WCNDGRTPGS RNLCNIPCSA LLSSDITASV NCAKKIVSDG
121 NGMNAWVAWR NRCKGTDVQA WIRGCRL

Figure 28: Amino acid sequence of chicken lysozyme with highlighted lysine residues.

To determine the amino acid sites of glycation, the non-glycated and lysozyme glycated
with D-galactose and D-glucose samples reduced with NaBH4 were separately reacted with
trypsin, and the tryptic digest from each was analyzed by MALDI-TOF mass spectrometry. The
resultant tryptic peptide mass fingerprint spectra for lysozyme condensed with D-galactose
(Figure 29B) and D-glucose (Figure 29C) are shown in Figure 29. The experimental molecular
weights obtained for the tryptic peptides were then compared with the molecular weights for a
theoretical lysozyme tryptic digest to identify putative glycated peptides. Two peptides were
identified which had mass shifts of +164 Da greater than the theoretical peptides (indicated with
arrows in Figure 29).
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Figure 29: Reduced MALDI-TOF tryptic peptide mass fingerprint spectra of chicken
lysozyme incubated at 37°C for 3 days in the absence of sugar and (A), and in the presence
of D-galactose (B), and in the presence of D-glucose (C). All protein samples were reduced
with NaBH3 prior to digest and mass spectral analysis. The arrows designate glycated
peptides.
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One peptide with m/z 1804 in the unmodified, control lysozyme peptide mass fingerprint
spectrum (Figure 30A) was found to exhibit a mass shift. This peptide was found to condense
with one reduced D-galactose molecule (+164 Da) yielding a peak with m/z 1968 (Figure 30B),
and the same peptide was also found to condense with one reduced D-glucose molecule (+164
Da) yielding a peak with m/z 1968 (Figure 30C). Based on the primary sequence of chicken
lysozyme, the site of glycation was localized around peptide (aa 115-131) having an amino acid
sequence consisting of KIVSDGNGMNAWVAWR. In order to confirm that this was a glycated
peptide and identify the site of glycation, I obtained a tandem ESI-MS/MS CID mass spectrum
for this peptide. Figure 31 shows the CID fragmentation for the +2 ion corresponding to the
reduced glycated peptide at m/z 984. Analysis of the resulting y and b fragment ions produced
upon the collision induced dissociation of the peptide confirmed that the lysine residue at
position 115 was derivatized with a sugar residue. The b fragment ions present in the spectrum
demonstrated mass shifts of +164 Da corresponding to reduced glycated peptide fragments
which localized the glycation site to Lys 115. Another peptide with m/z 606 in the unmodified,
control lysozyme peptide mass fingerprint spectrum was found to exhibit a mass shift. This
peptide was also found to condense with one D-galactose molecule (+164 Da) yielding a peak at
m/z 770 (Figure 32B), and the same peptide was found to condense with one D-glucose molecule
(+164 Da) yielding a peak with m/z 770 (Figure 32C). The amino acid sequence of this peptide
(aa 19-23) was KVFGR. The sugar molecule should be attached at the lysine residue at position
19; however, I was unable to obtain a good, clean CID tandem mass spectrum for this peptide to
confirm the site of glycation. This was because the concentration of this peptide was very low
within the complex tryptic peptide mixture and there were interfering peptides with m/z values
too close to this peptide. Based upon all of these observations, the lysine residue at position 115
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seems to be the preferred site of glycation under my experimental conditions. In order for a
lysine residue to react with a sugar molecule, the lysine must be in its basic amine form with a
lone pair on the nitrogen residue which acts as a nucleophile for the reaction. The presence of
114

K beside the

115

115

K, encouraging it to form a Schiff base with sugars. Also, the presence of an acidic amino acid

K residue could enhance the nucleophilicity of the epsilon amino group of

nearby (119D) could increase the likelihood of the sugar undergoing an Amadori rearrangement.
The 115K residue is located on the surface of the folded protein in contact with the surroundings
making it accessible to the sugar residues (Figure 33). The catalytic active site of the lysozyme
enzyme consists of a glutamic acid residue at amino acid position 53 and an aspartic acid residue
at amino acid position 70. The

115

K residue is not located near the catalytic cleft (Figure 33);

therefore, I would not expect the glycation of this residue to interfere with the activity of the
enzyme.
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Figure 30: Reduced MALDI-TOF tryptic peptide mass fingerprint spectra of the
unmodified and glycated peptide formed when chicken lysozyme was incubated at 37°C for
3 days in the absence of sugar and (A), and in the presence of D-galactose (B), and in the
presence of D-glucose (C). K* represents a glycated lysine residue (∆m/z 164 Da).
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Figure 31: CID mass spectrum recorded on the (M+2H)+2 ion at m/z 984. The sequence of
the peptide is shown with the predicted y and b fragments. Ions observed in the spectrum
are underlined. K* represents a galactated lysine residue of 292 Da (i,e.,
loss series at m/z 975 and m/z 966 are characteristic of glycated peptides.
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115K).

The water

Figure 32: Reduced MALDI-TOF tryptic peptide mass fingerprint spectra of the
unmodified and glycated peptide at m/z 770 formed when chicken lysozyme was incubated
at 37°C for 3 days in the absence of sugar and (A), and in the presence of D-galactose (B),
and in the presence of D-glucose (C). K* represents a glycated lysine residue (∆m/z 164
Da).
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Figure 33: 3-D structure of chicken lysozyme. The 115K residue is show in yellow. The 70D
and the 53E residue which are the catalytic active sites for the enzyme are shown in yellow.
Adapted from the high-resolution three-dimensional structure available at the Protein Data
Bank PBD ID 4RW2.34

B. Human
The amino acid sequence for human lysozyme is shown in Figure 34 with all six lysine
residues highlighted. To determine the amino acid sites of glycation, the non-glycated and
lysozyme glycated with D-galactose and D-glucose samples reduced with NaBH4 were
separately reacted with trypsin, and the tryptic digest from each was analyzed by MALDI-TOF
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mass spectrometry. Unfortunately, I repeated this experiment several times, but I was never able
to get the trypsin to digest the human lysozyme protein. Each time I attempted to obtain a peptide
mass fingerprint spectrum I was only able to obtain intact protein mass spectra. I thought that
there may have been a component in the recombinant protein solution that was interfering with
the trypsin digest, so I separated the glycated, reduced protein by SDS-PAGE prior to the
digestion with trypsin. The resultant tryptic peptide mass fingerprint spectra for lysozyme
condensed with D-galactose is shown in Figure 35. There were only two prominent peptides in
the spectra, both of which are unmodified peptides. Even after separation, trypsin was not
digesting this protein efficiently enough to be able to identify glycated peptides. I tried
prolonging the digestion period for up to three days, but no better mass spectra were obtained. In
the future, I could try digesting the glycated protein with different proteolytic enzymes. This may
not result in the generation of peptides either, because trypsin is generally regarded as the best
enzyme for protein digestion experiments. Perhaps I may have some luck switching to the
chemical cyanogen bromide which cleaves proteins after methionine residues.

1 MKALIVLGLA LLSVTVQGKV FERCELARTL KRLGMDGYRG ISLANWMCLA KWESGYNTRA
61 TNYNAGDRST DYGIFQINSR YWCNDGKTPG AVNACHLSCS ALLQDNIADA AACAKRVVRD
121 PQGVRAWAAW RNRCQDRDVR QYVQGCGV

Figure 34: Amino acid sequence of human lysozyme with highlighted lysine residues.
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Figure 35: Reduced MALDI-TOF tryptic peptide mass fingerprint spectra of human
lysozyme incubated at 37°C for 3 days in the absence of sugar and (A) and in the presence
of D-galactose (B). All protein samples were reduced with NaBH3 prior to digest and mass
spectral analysis.
58

5- Effect of Glycation on Enzymatic Activity
A. Chicken
I determined the effect of protein glycation on the enzymatic activity of the protein by
measuring

the

enzyme’s

lytic

activity

against

Micrococcus

lysodeikticus

spectrophotometrically. This procedure could only be used for chicken lysozyme, because it
would not work for the recombinant human lysozyme protein (as stated by Sigma-Aldridge).
The absorbance value measured at a wavelength of 450 nm should decrease over time as
lysozyme lysis the bacteria cells. For the first experiment, I simply assayed solutions of
unmodified lysozyme, D-galactose, and D-glucose in buffer solution (Figure 36). The kinetic
profile of absorbance shown in Figure 36A shows that the procedure was successful for
measuring enzymatic activity. The kinetic profiles shown in Figures 36B and 36C indicate that
solutions of D-galactose and D-glucose on their own were not able to lyse the bacterial cells.
Next, I incubated chicken lysozyme with both D-galactose and D-glucose at 37°C for up to 33
days. Aliquots of the solutions were removed at different time points for enzymatic assay
analysis. Figure 37 shows the kinetic profile for unmodified lysozyme (Figure 37A) and
lysozyme glycated with D-galactose (Figure 37B) and D-glucose (Figure 37C) after three days
of incubation. The kinetic profiles for these samples are very similar, and the rate constants do
not differ significantly, indicating that protein glycation did not affect the enzymatic activity
of the protein. I know from previous experiments that there would still be a large amount of
unmodified protein even after three days of incubation; therefore, I decided to allow the
incubation to proceed for longer amounts of time to obtain even more glycated protein in
solution. Figure 38 shows the kinetic profile of the enzyme after 14 days of incubation, and
Figure 39 shows the kinetic profile after 33 days of incubation. All of the profiles remain
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similar in these figures, and again the rate constants do not differ significantly. In conclusion,
the kinetic values did not show any significant change between the control lysozyme and the
glycated lysozyme at any of the time points studied indicating that the initial glycation of the
protein did not affect its enzymatic activity.

Figure 36: UV-VIS absorption profile of a suspended solution of Micrococcus Lysodeikticus
bacterial cells at 450 nm over time in the presence of chicken lysozyme (A), D-galactose (B),
and D-glucose (C).
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Figure 37: UV-VIS absorption profile of a suspended solution of Micrococcus Lysodeikticus
bacterial cells at 450 nm over time after the addition of chicken lysozyme incubated in the
absence of sugar (A), in the presence of D-galactose (B), and in the presence of D-glucose
(C) for three days.
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Figure 38: UV-VIS absorption profile of a suspended solution of Micrococcus Lysodeikticus
bacterial cells at 450 nm over time after the addition of chicken lysozyme incubated in the
absence of sugar (A), in the presence of D-galactose (B), and in the presence of D-glucose
(C) for 14 days.
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Figure 39: UV-VIS absorption profile of a suspended solution of Micrococcus Lysodeikticus
bacterial cells at 450 nm over time after the addition of chicken lysozyme incubated in the
absence of sugar (A), in the presence of D-galactose (B), and in the presence of D-glucose
(C) for 33 days.
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